Houston Methodist CV

Join us in Houston for the 14th Annual Re-Evolution Minimally Invasive Cardiac Surgery Summit. 📅 March 26–27, 2026 📍 Houston Methodist Research Institute | Houston, TX

Huge congrats to Eniko Pomozi for winning First Prize #AVF2026 @VenousForum! Proud of our lab @HMethodistCV where we combine MRI, histo, human thrombus to understand clot biology and treatment. Amazing work by Eniko + team. Check us out at European Venous Forum in June!

One of the most meaningful evolutions in the 2026 ACC/AHA dyslipidemia guideline is the continued elevation of CAC as a central tool in preventive decision-making. We have come a long way. 1. In the 2013 guidelines, CAC was effectively sidelined. 2. By 2019, it re-emerged as a decision aid. 3. In 2026, it is now clearly embedded in the framework of risk assessment, treatment initiation, and treatment intensity. Two messages stand out. 1. First, CAC has become the preferred decision aid when treatment decisions are uncertain. This is not an uncommon situation. In real-world practice, uncertainty is the rule rather than the exception, especially in borderline or intermediate-risk individuals. #PowerOfZero provides a clear distinction who is and not at risk that for the decision whether lipid-lowering therapy should be initiated. 2. Second, the guideline goes beyond initiation. CAC is increasingly used to guide the intensity of therapy. Increasing plaque burden corresponds to progressively more aggressive LDL targets and therapeutic strategies. For example, individuals with CAC ≥300–1000 are recommended to pursue LDL reduction strategies approaching secondary prevention intensity, reflecting event rates comparable to treated ASCVD populations. This is a MAJOR shift. CAC is no longer simply a tie-breaker for statin decisions. It is evolving into a disease-guided framework for preventive intensity. From a practical standpoint, this matters.Risk equations estimate probability. CAC visualizes disease. 1. When uncertainty exists, seeing the burden of atherosclerosis often changes the conversation for both clinician and patient. 2. It also aligns therapy more closely with biology (GREATER DISEASE, MORE INTENSE THE TREATMENT) rather than risk-factor projections alone. IN 2026. CAC has moved from the margins of guidelines to the center of preventive cardiology. For clinicians, that represents one of the most practical advances in translating risk assessment into actionable care. Congrats @rblument1 @RonBlankstein @DrMichaelShapir & rest of the guideline authors @AJPCardio @ASPCardio @MichaelJBlaha @Sadeer_AlKindi @HMethodistCV

It was a pleasure participating in the 8th Annual Houston Shock Symposium. Congrats to @JumeanMarwan for another outstanding conference & for continuing to expand & evolve this vision each year. Grateful for the thoughtful inclusion of imaging as a 🔑 component in the diagnosis & management of cardiogenic shock! #CardioX #CardioTwitter #HSS26 #EchoFirst #iecho

The Houston Methodist Team at #CRT2026. 💪🏼 @SachinGoelMD, NKleiman, @AlpeshShahMD, @Joe_Aoun_, SLittle, @haisummaqsood, @mderdem3, @KrityaMangesh, FreddyDuarte, FarazAnwar. @CRT_meeting, @DeBakeyCVedu, @HMethodistCV.

Professor of Cardiovascular Surgery Dr. @MReardon19 will be interviewed for Cardiotube at #CRT2026 on the six-year outcomes of patients with aortic stenosis in the Evolut Low Risk Trial. spr.ly/6019B66PmV

Director of Coronary Interventions Dr. @AlpeshShahMD will present at #CRT2026 on the role of coronary physiology for non-culprit lesions in ACS and CTO revascularization in ejection fraction. spr.ly/6014B66Tbg

Assistant Professor of Cardiology Dr. @Joe_Aoun_ will be at #CRT2026 moderating a session on understanding the latest data in mitral valve repair. He will also present on TAVR-in-TAVR procedural planning and execution. spr.ly/6015B66rqv

Our cardiologist Dr. @SachinGoelMD will be a presenter, moderator and panelist across multiple valve and structural heart sessions at #CRT2026. spr.ly/6019B66REz

Our cardiologist Dr. Neal Kleiman will be a panelist on a late breaking clinical trials session and a moderator on a session on STEMI contemporary topics at #CRT2026. spr.ly/6011B66RFc

🚨 Registration Is Now Open 🚨 📅 March 26–27, 2026 📍 Houston Methodist Research Institute | Houston, TX 🔗 Register and learn more: 👉 lnkd.in/gfSMtTn6 Watch: lnkd.in/ggHCa_MJ

@HMethodistCV And I am so grateful and excited to be here ! 🙏🏽♥️🫀

We recruited internationally recognized cardiologist @DrMarthaGulati to lead our new Davis Women’s Heart Center, marking a major investment in the prevention, diagnosis and treatment of heart disease in women. spr.ly/6019hJxil

Loved seeing the unveiling of our new Davis Women's Heart Center last week! Looking for young energetic cardiologists that might want to work here with us. If you are trained in INOCA, MINOCA and/or SCAD, and job hunting, please meet me at #ACC26 or DM me! We have the best team! #Savingwomenshearts #DavisWHC @HMethodistCV

Honored to keynote CSVS Winter Meeting w/ those who trained me incl. mentor @AndrewDueckMD. Spoke about transforming PAD care through a world-class translational lab @HMethodistCV, an ecosystem that few places globally could launch. Grateful for @AlanLumsdenMD vision and trust.

I am excited to announce that Dr Dhaval Parekh ⁦⁩has officially joined our #ACHD team ⁦@HMethodistCV⁩ as Director of ACHD Interventions and Director of CTEPH interventions. Looking forward to his amazing contributions ✅💚 ⁦@ACCinTouch⁩ ⁦@ACHA_Heart⁩ ⁦

Join us at #HoustonMethodist exhibit booth #2443 during the #ACC Conference on March 28-30, 2026, in the heart of New Orleans, Louisiana. We can't wait to see you there! #ACC26 #DeBakeyCVEducation

Congratulations to @DrMarthaGulati who was named the 2026 recipient of the Dr. Carolyn McCue Award for Woman Cardiologist of the Year by @VCUHealthHeart. This award recognizes her research on gender differences in CVD and her significant contributions to women’s heart health.

In contrast to pediatric-based models, our ACHD Program operates entirely in an adult heart hospital setting — improving continuity for adult complications without fragmented handoffs. spr.ly/6011hJxV1

A Green One Health framework for cardiology, advocated by Dr. @Sadeer_AlKindi and team, is organized into 3 pillars: 1) nature as a health care delivery platform; 2) nutrition as a nature-based intervention; and 3) cardiology’s footprint on nature. spr.ly/6012CaOQo